How PBI/Gordon Companies leveraged our Sirolimus API Market report
VM Intelligence · Sample preview · Healthcare and Pharmaceuticals · Forecast 2027–2033
Professional Grade Wearable Medical Devices Market
- By Device Type: Wearable ECG Monitors, Continuous Glucose Monitors (CGM), Wearable Blood Pressure Monitors, Pulse Oximeters, Wearable Temperature Sensors
- By End User: Hospitals, Ambulatory Surgical Centers, Home Healthcare, Diagnostic Laboratories, Rehabilitation Centers
- By Technology: Photoplethysmography (PPG) Sensors, Electrocardiography (ECG) Sensors, Electromyography (EMG) Sensors, Accelerometer-based Activity Trackers, Bioimpedance Sensors
- By Application: Cardiac Monitoring, Diabetes Management, Respiratory Monitoring, Neurological Monitoring, Fitness and Activity Tracking
- By Connectivity Type: Bluetooth-enabled Devices, Wi-Fi Enabled Devices, Cellular-enabled Devices, USB-connected Devices
Key Highlights
A snapshot of what the full report proves- 01 Market size - $X,XXX.XM global market in 2025 - the verified base-year revenue. Executive Summary →
- 02 Forecast - Full 2033 market projection modelled inside - unlock the forecast value to see where the market lands. Market Outlook →
- 03 Growth - Year-by-year CAGR across 2027–2033 - unlock the growth rate and the full model. Market Outlook →
- 04 Leading segment - Wearable ECG Monitors leads By Device Type at XX% share. Market, by Service Type →
- 05 Global coverage - Sized across 5 regions and 20 countries, each broken out by segment. Market, by Geography →
- 06 Competitive landscape - 16 companies profiled with SWOT, benchmarking and market-share analysis. Company Profiles →
Inside the Report
12 chapters · 305 pages- 01 Introduction Definition, segmentation & scope p.12 →
- 02 Research Methodology How the numbers were built p.20 →
- 03 Executive Summary The market in one chapter p.34 →
- 04 Market Outlook Drivers, restraints, trends p.66 →
- 11 Competitive Landscape 5 sections p.184 →
- 12 Company Profiles 16 players: SWOT & benchmarking p.192 →
Full report · locked preview
Everything inside the Professional Grade Wearable Medical Devices Market report
A complete, evidence-based study - 12 chapters and 128 sections covering market size, segmentation across 5 axes, regional analysis and 16 company profiles, forecast to 2033.
Segmentation covered
Device Type 5
End User 5
Technology 5
Application 5
Connectivity Type 4
Companies profiled
Medtronic plc
Abbott Laboratories
Philips Healthcare
GE Healthcare
Boston Scientific Corporation
Dexcom Inc.
Masimo Corporation
BioTelemetry
Inc. (now part of Philips)
Fitbit (Google LLC)
Garmin Ltd.
iRhythm Technologies Inc.
+4 more
Verified · Analyst-reviewed · No payment to preview
Trusted & certified by
★★★★★ Excellent
★★★★★ Excellent
16 players profiled - tiered by revenue contribution, footprint and R&D capability.
ACE Matrix · p.153 →Medtronic plc
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.155 →Abbott Laboratories
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.160 →Philips Healthcare
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.166 →GE Healthcare
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.173 →Boston Scientific Corporation
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.178 →Dexcom Inc.
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.184 →Masimo Corporation
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.191 →BioTelemetry
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.196 →Inc. (now part of Philips)
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.202 →Fitbit (Google LLC)
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.209 →Garmin Ltd.
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.214 →iRhythm Technologies Inc.
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.220 →Omron Healthcare Inc.
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.227 →Withings
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.232 →AliveCor Inc.
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.238 →ResMed Inc.
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.245 →Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Global · 2025–2033
$9,939M by 2033 · 11.0% CAGR
Market estimates & forecast (USD Million)
Fig. 15 · p.34 →Segment mix, 2033 (% share)
Fig. 16 · p.35 →- Wearable ECG Monitors35.5
- Continuous Glucose Monitors (CGM)11.1
- Wearable Blood Pressure Monitors24.6
- Pulse Oximeters13.3
- Wearable Temperature Sensors15.5
Regions, 2025 → 2033 (USD Mn)
§6.1 · p.75 →North America$1,428M → $3,216M · 10.7%
Europe$995.0M → $2,179M · 10.3%
Asia Pacific$908.5M → $2,049M · 10.7%
Latin America$562.4M → $1,396M · 12.0%
Middle East and Africa$432.6M → $1,089M · 12.2%
Top countries, 2033 (USD Mn)
§6.2 · p.78 →Year-over-year growth (%)
§3.12 · p.44 →10.902026
10.922027
10.942028
10.942029
10.952030
10.962031
10.992032
11.002033
CAGR by region (%)
Fig. 22 · p.71 →Market share by company, 2033 (%)
Fig. 41 · p.152 →- Medtronic plc22.3
- Abbott Laboratories20.9
- Philips Healthcare7.4
- GE Healthcare8.5
- Boston Scientific Corporation7.8
- Dexcom Inc.5.1
- Others28.0
Segment contribution to growth (%)
Fig. 18 · p.39 →Device Type11.0%
End User15.5%
Technology23.6%
Application24.0%
Connectivity Type25.9%
Competitive positioning (ACE matrix)
Fig. 40 · p.153 →Adoption & penetration (% of addressable)
Fig. 12 · p.31 →Revenue by application (USD Mn)
§5.3 · p.62 →Demand by end-use (USD Mn)
§5.4 · p.66 →Average selling price trend (index, 2025=100)
Fig. 27 · p.58 →Top companies by revenue, 2033 (USD Mn)
Fig. 42 · p.155 →Revenue by region, 2033 (%)
Fig. 20 · p.70 →- North America32.4
- Europe21.9
- Asia Pacific20.6
- Latin America14.1
- Middle East and Africa11.0
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
8 players benchmarked across 6 dimensions — scored 0–100 from share, portfolio, reach, innovation, financials and installed base. Methodology · §8.1 · p.160 →
Competitive scorecard (score 0–100)
Table 31 · p.161 →| Company | Market share | Product portfolio | Geographic reach | Innovation & R&D | Financial strength | Customer base | Composite |
|---|---|---|---|---|---|---|---|
| Medtronic plc | 88 | 97 | 95 | 94 | 81 | 92 | 91 |
| Abbott Laboratories | 77 | 73 | 77 | 69 | 71 | 76 | 74 |
| Philips Healthcare | 73 | 84 | 68 | 85 | 81 | 85 | 79 |
| GE Healthcare | 66 | 73 | 58 | 76 | 61 | 73 | 68 |
| Boston Scientific Corporation | 71 | 63 | 54 | 54 | 71 | 74 | 65 |
| Dexcom Inc. | 53 | 62 | 66 | 67 | 48 | 58 | 59 |
| Masimo Corporation | 45 | 62 | 53 | 46 | 45 | 60 | 52 |
| BioTelemetry | 58 | 37 | 48 | 49 | 52 | 58 | 50 |
Vendor positioning (presence × innovation)
Fig. 43 · p.163 →Strengths profile (top 3 players)
Fig. 44 · p.165 →- Medtronic plc
- Abbott Laboratories
- Philips Healthcare
Capability coverage
§8.3 · p.168 →| Company | Global delivery | R&D depth | Digital platform | Sustainability | After-sales | Custom solutions |
|---|---|---|---|---|---|---|
| Medtronic plc | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ |
| Abbott Laboratories | ◐ | ◐ | ◐ | ◐ | ◐ | ✓ |
| Philips Healthcare | ◐ | ✓ | ✓ | ✓ | ✓ | ✓ |
| GE Healthcare | ◐ | ✓ | ◐ | ◐ | − | ◐ |
| Boston Scientific Corporation | ✓ | ◐ | − | − | ◐ | ◐ |
| Dexcom Inc. | − | − | − | ◐ | − | − |
| Masimo Corporation | ◐ | ◐ | − | − | − | ◐ |
| BioTelemetry | ◐ | − | ◐ | − | − | ◐ |
✓ Full ◐ Partial − Limited
Overall competitive index (composite, ranked)
Fig. 45 · p.170 →1Medtronic plc91
2Philips Healthcare79
3Abbott Laboratories74
4GE Healthcare68
5Boston Scientific Corporation65
6Dexcom Inc.59
7Masimo Corporation52
8BioTelemetry50
Competitive tiers
§8.4 · p.172 →Leader2
Set the pace on share, breadth and innovation.
Medtronic plcPhilips Healthcare
Challenger2
Strong scale, closing on the leaders.
Abbott LaboratoriesGE Healthcare
Contender2
Focused players with pockets of strength.
Boston Scientific CorporationDexcom Inc.
Niche2
Specialists in a single segment or region.
Masimo CorporationBioTelemetry
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Go-to-market strategy
Land Device Type in North America, then scale across Professional Grade Wearable Medical Devices Market — a $110M beachhead inside a $1.58B market.
Beachhead (SOM)$110Mobtainable near-term
Serviceable (SAM)$629Mreachable market
Primary motionDirect + partner-ledgo-to-market
Time to scale6 Qto full motion
Ideal customer profile (who to sell to)
§GTM 1 · p.190 →Champion91 fit
Wearable ECG Monitors
Best fit — highest urgency & budget in Device Type.
Economic buyer80 fit
Continuous Glucose Monitors (CGM)
Strong fit — clear ROI and a fast path to value.
End user66 fit
Wearable Blood Pressure Monitors
Emerging fit — growing demand, longer sales cycle.
Market-entry sequence (beachhead → scale)
Fig. GTM 1 · p.192 →Beachhead · 2025–2026
Win Device Type in North America
Concentrated ICP, fastest proof and references.
Expand · 2026–2028
Add End User & next regions
Repeat the motion in adjacent, look-alike segments.
Scale · 2028–2033
Full-market coverage + Technology
Multi-channel, platform & ecosystem plays.
Channel mix (routes to market)
§GTM 3 · p.195 →Direct sales47%
Partner / channel28%
Digital / self-serve18%
Marketplaces8%
Positioning & messaging
§GTM 2 · p.194 →For Device Type leaders who need defensible market intelligence, VM Intelligence is the fastest, source-cited way to size, segment and win Professional Grade Wearable Medical Devices Market — unlike generic, static research.
Live & source-cited
Every figure triangulated from 600K+ sources and traceable.
Ready in minutes
A full, tailored report compiled on demand — not weeks.
Scope you control
Pick the chapters, regions and companies that matter.
GTM funnel & unit economics (conversion · CAC / LTV)
Fig. GTM 2 · p.198 →Awareness100%
Marketing qualified40%
Sales qualified20%
Evaluation11%
Closed-won6%
$17.9KCAC
$105KLTV
5.9:1LTV : CAC
< 4 moCAC payback
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Investment thesis
Professional Grade Wearable Medical Devices Market is a durable-growth opportunity — $9.06B by 2033, compounding at 6.9%.
TAM · 2025$5.31Btoday
TAM · 2033$9.06Bforecast
CAGR6.9%2027–2033
Cumulative$63.4Brevenue opportunity
Market opportunity (TAM · SAM · SOM)
Fig. 3 · p.14 →TAM$9.06BTotal addressable market
SAM$3.49BServiceable available market
SOM$568MServiceable obtainable market
Growth trajectory (USD Million)
Fig. 4 · p.16 →Why invest now
§2.1 · p.10 →6.9% CAGR
Demand compounds through 2033, outpacing GDP across Device Type.
Global tailwinds
North America leads today; fastest gains coming from emerging regions.
Structural shift
Adoption in Device Type moving from early to mainstream — durable secular demand.
Consolidation upside
16+ players, no runaway leader — room to build scale and roll up share.
Investment highlights
§2.2 · p.12 →$9.06BLarge & growingTAM by 2033 at 6.9% CAGR
$3.49BServiceable nowreachable with today’s model
$568MBeachhead winobtainable near-term share
16+Fragmented fieldplayers — consolidation runway
Return scenarios (2033 market value)
Fig. 6 · p.22 →$7.07BBear4.5% CAGR
$9.06BBase6.9% CAGR
$11.6BBull9.1% CAGR
Key risks & mitigants
§9.1 · p.180 →- Input-cost volatilityLong-term supply contracts & hedging
- Regulatory / policy shiftsDiversified exposure across 5 regions
- Technology disruptionR&D pipeline & End User optionality
- Customer concentrationBroaden installed base beyond top accounts
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Board pack · executive summary
Professional Grade Wearable Medical Devices Market — a $8.98B market by 2033. Plan: grow share from 7.7% to 14.1%.
Market size · 2033$8.98Btotal addressable
Market CAGR9.2%2027–2033
Target share14.1%from 7.7% today
Revenue ambition$1.27Bby 2033
Strategic scorecard (current vs 2033 target)
Table 1 · p.6 →| Objective | Current | Target · 2033 | Status |
|---|---|---|---|
| Market share | 7.7% | 14.1% | At risk |
| Revenue | $655M | $1.27B | Behind |
| Geographic coverage | 2 of 5 regions | 5 of 5 regions | At risk |
| Segment coverage | 3 of 5 axes | 5 of 5 axes | Behind |
| Gross margin | 35.6% | 43.3% | Behind |
| Customer retention | 88.1% | 92.6% | On track |
Where to play (strategic priorities)
§1.2 · p.8 →1
Lead segment
Win in Device Type
Largest revenue pool and fastest secular demand — concentrate to build share here first.
2
Geographic
Expand across North America & beyond
Deepen the leading region, then scale into the fastest-growing emerging markets.
3
Adjacency
Build End User capability
A defensible second engine — invest in End User to widen the moat and cross-sell.
Strategic roadmap (2025–2033)
Fig. 1 · p.10 →Phase 1 · Foundation
2025–2027
- Secure core Device Type share
- Fix unit economics
- Stand up data & ops
Phase 2 · Scale
2028–2030
- Enter new regions
- Launch End User
- Selective M&A
Phase 3 · Lead
2031–2033
- Category leadership
- Premium mix & margin
- Platform & ecosystem
Board decisions & asks
§1.4 · p.14 →- Approve $152M capacity & capability investment
- Greenlight bolt-on M&A in End User
- Authorise North America expansion plan
- Fund R&D program for Device Type leadership
Risk watchlist (RAG)
§9 · p.180 →- Demand / macro slowdownAhead
- Competitive share lossBehind
- Input-cost & supply riskAhead
- Regulatory / policy changeOn track
- Execution & talentOn track
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Sales deck · value proposition
Win the Professional Grade Wearable Medical Devices Market conversation — a $1.37B market you can size, segment and defend in minutes.
Market size · 2033$1.37Btotal opportunity
Growth4.5%CAGR to 2033
Addressable buyers1,728+accounts in scope
Typical ROI4.7×in year one
Who buys (target personas)
§1.1 · p.4 →Product / BU leader
Head of Device Type
Goal Grow share in Device Type
Pain Blind spots on demand, pricing & competitors.
Regional GM
North America lead
Goal Prioritise the right markets
Pain No granular, country-level view of the market.
M&A / strategy
Strategy & Corp Dev
Goal Find where to invest or acquire
Pain Slow, inconsistent third-party research.
From pain to solution
§1.2 · p.6 →Decisions made on stale, generic dataLive, source-cited figures, continuously updated
Weeks waiting on a research vendorA full report compiled in minutes
No view of competitors or whitespaceCompany profiles, ACE matrix & benchmarking
Hard to defend the numbers internallyEvery figure traceable to its original source
The business case (ROI)
Fig. 2 · p.9 →4.7×return on cost, year one
< 3 mopayback period
$51K+research cost avoided
10×faster than a custom study
Time to insight
Cost to run
Risk of a wrong call
Why buyers trust it (proof points)
§1.3 · p.12 →600K+source studies indexed
100%analyst-reviewed
16+players profiled in this market
Coverage includes
Medtronic plcAbbott LaboratoriesPhilips HealthcareGE HealthcareBoston Scientific CorporationDexcom Inc.Masimo CorporationBioTelemetry+8 more
Objection handling
§1.4 · p.14 →“We already have market data.”
This triangulates 600K+ sources into one current, defensible view — not another silo.
“How do we know it’s accurate?”
Analyst-reviewed, and every figure is source-cited and traceable to its origin.
“It’s not in the budget.”
A fraction of a single analyst-day — and it pays back on the first decision it informs.
“We need it tailored to us.”
Choose the chapters, regions and companies before you build — you only pay for scope.
What you get (packages)
§1.5 · p.16 →Report
- Full multi-chapter report
- Market size, share & forecast
- Segment & regional breakdowns
- PDF + editable Excel + PPT
Most popular
Report + Add-ons
- Everything in Report
- Interactive Visualizer
- Competitive benchmarking
- Investor / board / sales decks
Enterprise
- Multiple reports & markets
- Team seats & sharing
- Analyst support & custom scope
- API / data-feed options
Almost there
Access your Professional Grade Wearable Medical Devices Market report
Sign in to unlock the full report - it’s compiled live and ready in minutes.
or continue with your email
Your report is ready to access
Professional Grade Wearable Medical Devices Market Report is ready
Verify your email to unlock it. We sent a 6-digit code to your inbox.
That code is invalid or expired. Please try again.
Trusted by strategy, finance & consulting teams
Related Reports
Healthcare and Pharmaceuticals · scroll →Professional ENT Chairs Market
Market size, share, segmentation and regional forecast.
$5.2B market · 2025 base year
View reportProfessional Dentist Chair Market
Market size, share, segmentation and regional forecast.
$2.6B market · 2025 base year
View reportProfessional Defibrillator Market
Market size, share, segmentation and regional forecast.
$5.8B market · 2025 base year
View reportProfessional Blood Pressure Monitor Market
Market size, share, segmentation and regional forecast.
$4.3B market · 2025 base year
View reportProfessional Antibacterial Mask Market
Market size, share, segmentation and regional forecast.
$2.3B market · 2025 base year
View reportProfessional Aesthetic Laser Devices Market
Market size, share, segmentation and regional forecast.
$3.3B market · 2025 base year
View reportProfessional Aesthetic Device Market
Market size, share, segmentation and regional forecast.
$5.7B market · 2025 base year
View reportProducts NameIntervertebral Disc Microsurgical Instruments Market
Market size, share, segmentation and regional forecast.
$3.7B market · 2025 base year
View reportProduct Quality and Safety Traceability Solution Market
Market size, share, segmentation and regional forecast.
$4.8B market · 2025 base year
View reportProduction Quality Control of In Vitro Diagnostic Reagents Market
Market size, share, segmentation and regional forecast.
$6.0B market · 2025 base year
View reportProcyanidin B3 Reagent Market
Market size, share, segmentation and regional forecast.
$1.4B market · 2025 base year
View reportProctologic Table Market
Market size, share, segmentation and regional forecast.
$2.3B market · 2025 base year
View reportThe showdown
Custom-built vs. off-the-shelf
Scroll to watch them go head-to-head
WinnerVMR Custom Report
- Tailored to your exact scope
- Delivered in minutes
- Live, always-current data
- Fully editable data (XLSX)
- You choose the companies
- Source-cited & traceable
Off-the-shelf PDF
- Generic, one-size template
- Waits 2–5 days
- A fixed snapshot in time
- Locked, flat PDF
- Preset company list
- Opaque sourcing
Customer Testimonials
Proof from industry leaders who rely on us
These stories come from the executives who depend on VMR’s intelligence for market entry, expansion, assessment, and planning. Their outcomes and experiences reflect our commitment to clarity.
600,000+source studies indexed
100%analyst-reviewed
Every figuresource-cited & traceable
In their words
Watch clients tell their story
How VMR helped University of Limerick with Anesthesia Monitoring Devices
How VMR helps brands expand into Africa & emerging markets
Unlock your GTM strategy: an Elsewedy Electric success story
Beyond sales data: layering NielsenIQ data to support strategy
How VMR became the trusted partner for United Alloy
Questions, answered
How is the research actually conducted?
Every report is compiled from VMR’s continuously-updated intelligence across 600,000+ source studies - primary interviews, company filings, trade data, and government & industry databases. Figures are triangulated across multiple credible sources, then reviewed by a research analyst before your report is delivered.
What exactly do I get inside the report?
A full multi-chapter study: market definition & methodology, executive summary, market outlook (drivers, restraints, trends, Porter’s Five Forces), segment deep-dives, regional & country breakdowns, competitive landscape, and a full profile for every company you select - with interactive charts and data tables throughout.
How accurate are the numbers, and can I trust them?
Market sizing is reconciled across leading sources (Gartner, BCG, MarketsandMarkets, government bodies and more), with outliers removed and a confidence-graded median used for the base year. Every figure is source-cited and traceable to its origin, and an analyst validates the model before delivery.
Can I customise the chapters, regions and companies?
Yes. Choose exactly the chapters, regions and countries, and the companies you want benchmarked before you build - then adjust your selection and recompile anytime from your account. You only pay for the scope you need.
What formats do I receive, and is the data editable?
Every report is readable online in full. Downloadable formats are available as optional $99 add-ons: a formatted PDF and a fully editable XLSX containing all underlying data tables - so you can re-chart, re-model, or drop any figure straight into your own deck.